top of page

Tumor Ablation Market Trends, Share Analysis, Growth Drivers, and Forecast 2025-2033

  • Writer: Rahul Pal
    Rahul Pal
  • Dec 2, 2024
  • 3 min read

ree

According to the latest report by IMARC Group, titled “Tumor Ablation Market Report by Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), Mode of Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), End-User (Hospitals, Cancer Specialty Clinics, and Others), and Region 2025-2033”, offers a comprehensive analysis of the industry, which comprises insights on the global tumor ablation market trends. The report also includes competitor and regional analysis, and contemporary advancements in the global market.


The global tumor ablation market size reached USD 1,310 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,200 Million by 2033, exhibiting a growth rate (CAGR) of 10.4% during 2025-2033.


The global tumor ablation market is experiencing significant growth driven by several key factors that cater to the increasing need for effective cancer treatments. Tumor ablation involves minimally invasive techniques to destroy cancer cells using methods such as radiofrequency, microwave, cryoablation, and laser ablation. These procedures are widely used to treat various types of tumors in organs such as the liver, lungs, kidneys, and bones. Furthermore, the rising prevalence of cancer worldwide is a major driver of the tumor ablation market. As the global incidence of cancer continues to increase, there is a growing demand for effective and less invasive treatment options. Tumor ablation offers advantages such as reduced recovery times, lower risk of complications, and the ability to target tumors that are difficult to reach with traditional surgical methods.


Moreover, technological advancements and innovations in tumor ablation techniques significantly contribute to market growth. Continuous developments in imaging technologies, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), enhance the precision and effectiveness of ablation procedures. These advancements allow for better visualization and targeting of tumors, improving treatment outcomes and patient safety.



Tumor Ablation Market Trends:


From a market scope and analysis perspective, the global tumor ablation market encompasses various product types, including radiofrequency ablation devices, microwave ablation devices, cryoablation devices, and laser ablation systems. The market also includes a range of applications, such as liver cancer, lung cancer, kidney cancer, bone metastasis, and others. The increasing adoption of minimally invasive procedures and the rising preference for outpatient settings further drive market expansion.


Geographically, North America and Europe are key markets for tumor ablation, driven by advanced healthcare infrastructure, high cancer prevalence, and the presence of leading medical device manufacturers. The Asia-Pacific region is also witnessing significant growth, supported by improving healthcare facilities, increasing awareness about cancer treatments, and a growing patient pool. As healthcare providers and patients seek more effective and less invasive cancer treatments, the demand for innovative tumor ablation technologies is expected to remain strong, contributing to improved patient outcomes and the overall advancement of cancer care worldwide.


By the IMARC Group, Some of the Top Competitive Landscape Operating in the Global Tumor Ablation Market are Given Below:


  • Medtronic Public Limited Company

  • AngioDynamics Inc.

  • HealthTronics Inc.

  • NeuWave Medical, Inc.

  • INTIO Inc.

  • Galil Medical Ltd

  • Boston Scientific Corporation

  • SonaCare Medical LLC

  • EDAP TMS S.A.

  • Erbe Elektromedizin GmbH

  • IceCure Medical Ltd

  • MISONIX Inc.

  • Endocare Inc.

  • CooperSurgical Inc.

  • B V M Meditech Pvt


Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/tumor-ablation-market


Key Market Segmentation:


Breakup by Technology:


  • Radiofrequency (RF) Ablation

  • Microwave Ablation

  • Cryoablation

  • Others


Breakup by Mode of Treatment:


  • Percutaneous Ablation

  • Laparoscopic Ablation

  • Surgical Ablation


Breakup by Mode of Application:


  • Liver Cancer

  • Lung Cancer

  • Kidney Cancer

  • Bone Metastasis

  • Others


Breakup by End-User:


  • Hospitals

  • Cancer Specialty Clinics

  • Others


Regional Insights:


  • North America (United States, Canada)

  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)

  • Latin America (Brazil, Mexico, Others)

  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)


Key highlights of the Report:


  • Market Performance

  • Market Outlook 

  • COVID-19 Impact on the Market

  • Porter’s Five Forces Analysis

  • Historical, Current and Future Market Trends

  • Market Drivers and Success Factors

  • SWOT Analysis

  • Structure of the Market

  • Value Chain Analysis

  • Comprehensive Mapping of the Competitive Landscape


Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.


About Us


IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.


IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145


 
 
 

Comments


Never Miss a Post. Subscribe Now!

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Thanks for submitting!

© 2035 by Kathy Schulders. Powered and secured by Wix

  • Grey Twitter Icon
bottom of page